Aristeia Capital’s Core Scientific Inc Tranche 1 Warrants CORZW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111M Buy
5,885,331
+574,532
+11% +$9.67M 1.44% 17
2026
Q1
$46.4M Buy
5,310,799
+194,678
+4% +$2.09M 0.96% 20
2025
Q4
$43.2M Sell
5,116,121
-184,944
-3% -$2.05M 0.94% 23
2025
Q3
$61.3M Buy
5,301,065
+368,080
+7% +$3.12M 1.43% 16
2025
Q2
$53.4M Buy
4,932,985
+317,791
+7% +$1.58M 1.45% 19
2025
Q1
$14M Sell
4,615,194
-34,686
-0.7% -$213K 0.35% 44
2024
Q4
$38.2M Buy
4,649,880
+1,977,390
+74% +$17.9M 1.25% 15
2024
Q3
$18M Buy
2,672,490
+698,580
+35% +$3.85M 0.37% 24
2024
Q2
$8.87M Buy
+1,973,910
New +$4.01M 0.2% 38

Other funds holding CORZW

Aristeia Capital's CORZW Position: Q2 2026 in Review

Aristeia Capital increased its Core Scientific Inc Tranche 1 Warrants (CORZW) stake by 11% in Q2 2026, buying an estimated $9.67M and bringing the position to 5,885,331 shares worth $111M. The position accounts for 1.44% of the portfolio, ranked #17.

Aristeia Capital first reported a position in CORZW in Q2 2024 and has held it in 9 quarters since. 61 funds tracked by Wall St. Rank hold CORZW as of Q2 2026.

  • Aristeia Capital held 5,885,331 shares of Core Scientific Inc Tranche 1 Warrants worth $111M as of Q2 2026.
  • Aristeia Capital bought 574,532 Core Scientific Inc Tranche 1 Warrants shares in Q2 2026, an estimated $9.67M.
  • Core Scientific Inc Tranche 1 Warrants made up 1.44% of Aristeia Capital's portfolio in Q2 2026, its #17 holding.
  • Aristeia Capital first reported a position in Core Scientific Inc Tranche 1 Warrants in Q2 2024 and has held it in 9 quarters since.
  • 61 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 1 Warrants as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.